IP Library Granted Patent US 7,442,508
Granted Patent B2
US 7,442,508 · App. 11/414,760 · Granted Oct 28, 2008

Methods for detection and production of influenza viruses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,508
App. No.
11/414,760
Granted
Oct 28, 2008
Kind
B2
Abstract

The present invention generally relates to the field of diagnostic microbiology, and, more particularly, to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of organisms to antimicrobial agents.

Claims (24)

1. A method for the production of influenza virus, comprising the steps of:

a) providing:

i) a sample containing an influenza virus; and

ii) a serum-free, trypsin-containing cell culture medium comprising cells, said cells consisting of mink lung cells;

b) inoculating said mink lung cells with said sample to produce inoculated mink lung cells, wherein said inoculated mink lung cells produce said influenza virus.

2. The method of claim 1 , wherein said influenza virus is Influenza A.

3. The method of claim 1 , wherein said influenza virus is Influenza B.

4. A method for the production of influenza virus, comprising the steps of:

a) providing:

i) a sample containing an influenza virus; and

ii) a serum-free, trypsin-containing cell culture medium comprising cells, said cells consisting of Mv1Lu cells;

b) inoculating said Mv1Lu cells with said sample to produce inoculated Mv1Lu cells, wherein said inoculated Mv1Lu cells produce said influenza virus.

5. The method of claim 4 , wherein said influenza virus is Influenza A.

6. The method of claim 4 , wherein said influenza virus is Influenza B.

7. The method of claim 4 , wherein said serum-free, trypsin-containing cell culture medium is RM03T.

8. A method for the production of influenza virus, comprising the steps of:

a) providing:

i) a sample containing an influenza virus;

ii) Mv1Lu cells; and

iii) a serum-free, trypsin-containing medium;

b) contacting said Mv1Lu cells with said medium to produce treated Mv1Lu cells;

c) inoculating said treated Mv1Lu cells with said sample to produce inoculated Mv1Lu cells, wherein said inoculated Mv1Lu cells produce said influenza virus.

9. The method of claim 8 , wherein said medium is RM03T.

10. The method of claim 8 , wherein said Mv1Lu cells have not been treated with sodium butyrate.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
CHANGE OF NAME Recorded Mar 21, 2017
From: UNIVERSITY HOSPITALS OF CLEVELAND
To: UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
Reel/Frame 042742/0793 →
CHANGE OF ADDRESS Recorded Jan 12, 2017
From: DIAGNOSTIC HYBRIDS, INC.
To: DIAGNOSTIC HYBRIDS, INC.
Reel/Frame 041351/0846 →
NOTICE OF RELEASE OF GRANT OF PATENT SECURITY INTEREST Recorded Dec 1, 2016
From: BANK OF AMERICA, N.A., AS AGENT
To: DIAGNOSTIC HYBRIDGS, INC.
Reel/Frame 040788/0200 →
GRANT OF PATENT SECURITY INTEREST Recorded Feb 22, 2010
From: DIAGNOSTIC HYBRIDS, INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 023963/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2006
From: SCHOLL, DAVID R.; GOODRUM, PATRICIA GAIL RAY
To: DIAGNOSTIC HYBRIDS, INC.
Reel/Frame 018147/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2006
From: HUANG, YUNG T.
To: CLEVELAND, UNIVERSITY HOSPITALS OF
Reel/Frame 018147/0125 →